Abstract
In this work, the phase behavior variations of an ascorbyl palmitate (Asc16) system in aqueous solution were analyzed when immunologically active hydrophilic compounds (CpG and OVA) were introduced. This study was carried out through optical polarizing microscopy (OPM) and differential scanning calorimetry (DSC) at different temperatures and over a broad range of concentrations. The combination of both techniques allowed the determination of a complete phase diagram which was compared with those built for Asc16-water system and it was demonstrated that fixed concentrations of hydrophilic compounds (300 and 24 µg/g for CpG-ODN and OVA respectively) generate two lamellar liquid crystals, a cubic liquid crystal phase, and also other aggregates. However, no changes were observed in the phase diagram in terms of formation of new mesophases. The aqueous phase behavior was also studied as a function of surfactant and temperature. DSC and Fourier transform infrared spectroscopy (FT-IR) measurements show differences in the free water and mainly in the secondary hydration layer, which confirm that the studied compounds are situated in the aqueous domain. The construction and analysis of Asc16 phase diagrams with a fixed concentration of CpG-ODN/OVA allows the comprehension of Asc16 phase behavior and could be easily adapted to other concentrations. Moreover, these findings could be extrapolated to other hydrophilic substances in aqueous solution introduced in liquid crystal phases since they follow a similar behavior as those reported in the literature.
Similar content being viewed by others
References
Palma S, Lo Nostro P, Manzo R, Allemandi D (2002) Evaluation of the surfactant properties of ascorbyl palmitate sodium salt. Eur J Pharm Sci 16:37–43
Palma S, Manzo R, Allemandi D, Fratoni L, Lo Nostro P (2002) Solubilization of hydrophobic drugs in octanoyl-6-O-ascorbic acid micellar dispersions. Langmuir 18:1810–1816
Benedini L, Schulz E, Messina P, Palma S, Allemandi D, Schulz P (2011) The ascorbyl palmitate-water system: phase diagram and state of water. Colloids Surf A Physicochem Eng Aspects 375:178–185
Palma S, Ullio Gamboa G, Allemandi D (2013) Vitamin C based nanostructures: potential utility in ocular and transdermal therapy. J Biomater Tiss Eng 3:61–69
Ambrosi M, Lo Nostro P, Fratoni L, Dei L, Ninham BW, Palma S, Manzo R, Allemandi D, Baglioni P (2004) Water of hydration in coagels. Phys Chem Chem Phys 6:1401–1407
Palma S, Manzo R, Allemandi D, Fratoni L, Lo Nostro P (2003) Drugs solubilization in ascorbyl-decanoate micellar solutions. Colloids Surf A Physicochem Eng Aspects 212:163–173
Capuzzi G, Lo Nostro P, Kulkarni K, Fernandez J, Vincieri F (1996) Interactions of 6-O-stearoylascorbic acid and vitamin K1 in mixed Langmuir films at the gas–water interface. Langmuir 12:5413–5418
Capuzzi G, Lo Nostro P, Kulkarni K, Fernandez J (1996) Mixtures of stearoyl-6-O-ascorbic acid and -tocopherol: a monolayer study at the gas/water interface. Langmuir 12:3957–3963
Capuzzi G, Kulkarni G, Fernandez J, Vincieri J, Lo Nostro P (1997) Mixture of ascorbyl-stearate and vitamin D3: a monolayer study at the gas–water interface. J Colloid Interface Sci 186:271–279
Tartara I, Quinteros D, Saino V, Allemandi D, Palma S (2012) Improvement of acetazolamide ocular permeation using ascorbyl laurate nanostrucures as drug delivery systems. J Ocul Pharmacol Ther 28:102–109
Saino V, Monti D, Burgalassi S, Tampucci S, Palma S, Allemandi D, Chetoni P (2010) Optimization of skin permeation and distribution of ibuprofen by using nanostructures (coagels) based on alkyl vitamin C derivatives. Eur J Pharm Biopharm 76:443–449
Palma S, Maletto B, Lo Nostro P, Manzo R, Pistoresi-Palencia M, Allemandi D (2006) Potential use of ascorbic acid–based surfactants as skin penetration enhancers. Drug Dev Ind Pharm 32:821–827
Rasia M, Spengler M, Palma S, Manzo R, Lo Nostro P, Allemandi D (2011) Effect of ascorbic acid based amphiphiles on human erythrocytes membrane. Clin Hemorheol Microcirc 36:133–140
Pulendran B, Ahmed R (2011) Immunological mechanisms of vaccination. Nat Immunol 12:509–517
Hanagata N (2012) Structure-dependent immunostimulatory effect of CpG oligodeoxynucleotides and their delivery system. Int J Nanomed 7:2181–2195
Navarro G, Maiwald G, Haase R, Rogach A, Wagner E, Tros de Ilarduya C, Ogris M (2010) Low generation PAMAM dendrimer and CpG free plasmids allow targeted and extended transgene expression in tumors after systemic delivery. J Controll Rel 146:99–105
Gramzinski R, Doolan D, Sedegah M, Davis H, Krieg A, Hoffman S (2001) Interleukin-12- and gamma interferon-dependent protection against malaria conferred by CpG oligodeoxynucleotide in mice. Infect Immun 69:1643–1649
Rees D, Gates A, Green M, Eastaugh L, Lukaszewski R, Griffin K, Krieg AM, Titball RW (2005) CpG-DNA protects against a lethal orthopoxvirus infection in a murine model. Antivir Res 65:87–95
Mutwiri G, van DrunenLittel-van den Hurk S, Babiuk L (2009) Safety of CpG oligodeoxynucleotides in veterinary species. Adv Drug Deliv Rev 61:226–232
Krieg A (2006) Therapeutic potential of toll-like receptor 9 activation. Nat Rev Drug Discov 5:471–484
Mutwiri G, Nichani A, Babiuk S, Babiuk L (2004) Strategies for enhancing the immunostimulatory effects of CpG oligodeoxynucleotides. J Control Release 97:1–17
Mueller M, Reichardt W, Koerner J, Groettrup M (2012) Coencapsulation of tumor lysate and CpG-ODN in PLGA-microspheres enables successful immunotherapy of prostate carcinoma in TRAMP mice. J Control Release 162:159–166
Kwong B, Liu H, Irvine DJ (2011) Induction of potent anti-tumor responses while eliminating systemic side effects via liposome-anchored combinatorial immunotherapy. Biomaterials 32:5134–5147
Klier J, Fuchs S, May A, Schillinger U, Plank C, Winter G, Gehlen H, Coester C (2012) A nebulized gelatin nanoparticle-based CpG formulation is effective in immunotherapy of allergic horses. Pharm Res 29:1650–1657
Zhou S, Hashida Y, Kawakami S, Mihara J, Umeyama T, Imahori H, Murakami T, Yamashita F, Hashida M (2014) Preparation of immunostimulatory single-walled carbon nanotube/CpG DNA complexes and evaluation of their potential in cancer immunotherapy. Int J Pharm 471:214–223
Choksakulnimitr S, Masuda S, Tokuda H, Takakura Y, Hashida M (1995) In vitro cytotoxicity of macromolecules in different cell-culture systems. J Control Release 34:233–241
Rattanakiat S, Nishikawa SM, Funabashi H, Luo D, Takakura Y (2009) The assembly of a short linear natural cytosine-phosphate-guanine DNA into dendritic structures and its effect on immunostimulatory activity. Biomaterials 30:5701–5706
Klinman D, Barnhart K, Conover J (1999) CpG motifs as immune adjuvants. Vaccine. 17:19–25
Klinman D (2006) Adjuvant activity of CpG oligodeoxynucleotides. Int Rev Immunol 25:135–154
Xie H, Gursel I, Ivins B, Singh M, O’Hagan D, Ulmer J, Klindman D (2005) CpG oligodeoxynucleotides adsorbed onto polylactide-co-glycolide microparticles improve the immunogenicity and protective activity of the licensed anthrax vaccine. Infect Immun 73:828–833
Erikci E, Gursel M, Gursel I (2011) Differential immune activation following encapsulation of immunostimulatory CpG oligodeoxynucleotide in nanoliposomes. Biomaterials 32:1715–1723
Fischer S, Schlosser E, Mueller M, Csaba N, Merkle HP, Groettrup M, Gander B (2009) Concomitant delivery of a CTL-restricted peptide antigen and CpG ODN by PLGA microparticles induces cellular immune response. J Drug Target 17(8):652–661
McCluskie MJ, Weeratna RD, Evans DM, Makinen S, Drane D, Davis HL (2013) CpG ODN and ISCOMATRIX adjuvant: a synergistic adjuvant combination inducing strong T-cell IFN-gamma responses. Biomed Res Int 2013:636847
Sánchez Vallecillo M, Ullio Gamboa G, Palma S, Harman M, Chiodetti M, Morón G, Pstoresi C, Maletto B (2014) Adjuvant activity of CpG-ODN formulated as a liquid crystal. Biomaterials 35:2529–2542
Schulz PC (2006) Water structure at surfactant microstructures and biological interfaces. In: Somasundaran P, Hubbard A (eds) Encyclopedia of surface and colloid science, New York, pp 6562–6577
Maletto B, Ropolo A, Moron V, Pistoresi-Palencia MC (2002) CpG-DNA stimulates cellular and humoral immunity and promotes Th1 differentiation in aged BALB/c mice. JLB 72:447–454
Maletto B, Ropolo A, Liscovsky M, Alignani D, Glocker M, Pistoresi-Palencia M (2005) CpG oligodeoxinucleotides functions as an effective adjuvant in aged BALB/c mice. Clin Immunol 117:251–261
Connors K, Amidon G, Stella I (1986) Chemical stability of pharmaceuticals, Wiley-Interscience, New York
Rowe RC, Sheskey PJ, Cook W, Fenton ME (2012) Handbook of pharmaceutical excipients. American Pharmaceutical Association, Washington DC
Lo Nostro P, Ninham BW, Fratoni L, Palma S, Manzo RH, Allemandi D, Baglioni P (2003) Effect of water structure on the formation of coagels from ascorbylalkanoates. Langmuir 19:3222–3228
Schulz PC, Soltero-Martínez JFA, Puig JE (2001) DSC analysis of surfactant-based microstructures. In: Garti N (ed) Thermal behavior of dispersed systems. New York, pp 121–181
Herrera-Gómez A, Velázquez-Cruz G, Martín-Polo M (2001) Analysis of the water bound to a polymer matrix by infrared spectroscopy. J Appl Phys 89:5431–5437
Zhou G, Li G, Chen W (2002) Fourier transform infrared investigation on water states and the conformations of aerosol-OT in reverse microemulsions. Langmuir 18:4566–4571
Caboi F, Amico G, Pitzalis P, Monduzzi M, Nylander T, Larsson K (2001) Addition of hydrophilic and lipophilic compounds of biological relevance to the monoolein/water system. I. Phase behaviour. Chem Phys Lipids 109:47–62
Murgia S, Caboi F, Monduzzi M (2001) Addition of hydrophilic and lipophilic compounds of biological relevance to the monoolein:water system II—13C NMR relaxation study. Chem Phys Lipids 110:11–17
Acknowledgments
The authors would like to thank Dra. Olga Pieroni, (Organic Chemistry Laboratory-Chemistry department from UNS.INQUISUR-CONICET Bahia Blanca, Argentina) for assistance with the IR analysis. G. Ullio Gamboa thanks the Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET) for a research fellowship. This work was supported by the grants SECyT-UNC. Res. 162/12 and PID CONICET No. 11220090100673 and a grant of the Universidad Nacional del Sur. LAB, and DAA are researchers of CONICET.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Gabriela V. Ullio Gamboa and Luciano A. Benedini contributed equally to this work.
About this article
Cite this article
Ullio Gamboa, G.V., Benedini, L.A., Schulz, P.C. et al. Phase Behavior of Ascorbyl Palmitate Coagels Loaded with Oligonucleotides as a New Carrier for Vaccine Adjuvants. J Surfact Deterg 19, 747–757 (2016). https://doi.org/10.1007/s11743-016-1816-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11743-016-1816-9